Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;10(20):e15488.
doi: 10.14814/phy2.15488.

Kaempferol: A potential agent in the prevention of colorectal cancer

Hamid Reza Nejabati  1 , Leila Roshangar  1
Affiliations
Review

Kaempferol: A potential agent in the prevention of colorectal cancer

Hamid Reza Nejabati et al. Physiol Rep. 2022 Oct.

Abstract

Colorectal cancer (CRC) is the third most prevalent cancer in relation to incidence and mortality rate and its incidence is considerably increasing annually due to the change in the dietary habit and lifestyle of the world population. Although conventional therapeutic options, such as surgery, chemo- and radiotherapy have profound impacts on the treatment of CRC, dietary therapeutic agents, particularly natural products have been regarded as the safest alternatives for the treatment of CRC. Kaempferol (KMP), a naturally derived flavonol, has been shown to reduce the production of reactive oxygen species (ROS), such as superoxide ions, hydroxyl radicals, and reactive nitrogen species (RNS), especially peroxynitrite. Furthermore, this flavonol inhibits xanthine oxidase (XO) activity and increases the activities of catalase, heme oxygenase-1 (HO), and superoxide dismutase (SOD) in a wide range of cancer and non-cancer cells. Based on several studies, KMP is also a hopeful anticancer which carries out its anticancer action via suppression of angiogenesis, stimulation of apoptosis, and cell cycle arrest. Due to various applications of KMP as an anticancer flavonol, this review article aims to highlight the current knowledge regarding the role of KMP in CRC.

Keywords: anticancer; colorectal cancer; flavonol; kaempferol.

PubMed Disclaimer

Conflict of interest statement

The authors report there are no competing interests to declare.

Figures

FIGURE 1
FIGURE 1
Biosynthetic pathway of Kaempferol.
See this image and copyright information in PMC

References

    1. Abbas, T. , & Dutta, A. (2009). p21 in cancer: Intricate networks and multiple activities. Nature Reviews Cancer, 9, 400–414. - PMC - PubMed
    1. Akiyama, Y. , Kimura, Y. , Enatsu, R. , Mikami, T. , Wanibuchi, M. , & Mikuni, N. (2018). Advantages and disadvantages of combined chemotherapy with Carmustine wafer and bevacizumab in patients with newly diagnosed glioblastoma: A single‐institutional experience. World Neurosurgery, 113, e508–e514. - PubMed
    1. Alam, W. , Khan, H. , Shah, M. A. , Cauli, O. , & Saso, L. (2020). Kaempferol as a dietary anti‐inflammatory agent: Current therapeutic standing. Molecules, 25(18), 4073. - PMC - PubMed
    1. Alvarez, A. I. , Real, R. , Pérez, M. , Mendoza, G. , Prieto, J. G. , & Merino, G. (2010). Modulation of the activity of ABC transporters (P‐glycoprotein, MRP2, BCRP) by flavonoids and drug response. Journal of Pharmaceutical Sciences, 99, 598–617. - PubMed
    1. Amaral, J. D. , Xavier, J. M. , Steer, C. J. , & Rodrigues, C. M. (2010). The role of p53 in apoptosis. Discovery Medicine, 9, 145–152. - PubMed